104271,0,Admission,O
104271,0,Date,O
104271,0,:,O
104271,0,[,O
104271,0,*,O
104271,0,*,O
104271,0,2143-1-7,O
104271,0,*,O
104271,0,*,O
104271,0,],O
104271,0,Discharge,O
104271,0,Date,O
104271,0,:,O
104271,0,[,O
104271,0,*,O
104271,0,*,O
104271,0,2143-1-22,O
104271,0,*,O
104271,0,*,O
104271,0,],O
104271,0,Date,O
104271,0,of,O
104271,0,Birth,O
104271,0,:,O
104271,0,[,O
104271,0,*,O
104271,0,*,O
104271,0,2074-4-30,O
104271,0,*,O
104271,0,*,O
104271,0,],O
104271,0,Sex,O
104271,0,:,O
104271,0,M,O
104271,0,Service,O
104271,0,:,O
104271,0,MEDICINE,O
104271,0,Allergies,O
104271,0,:,O
104271,0,Patient,O
104271,0,recorded,O
104271,0,as,O
104271,0,having,O
104271,0,No,O
104271,0,Known,O
104271,0,Allergies,O
104271,0,to,O
104271,0,Drugs,O
104271,0,Attending,O
104271,0,:,O
104271,0,[,O
104271,0,*,O
104271,0,*,O
104271,0,First,O
104271,0,Name3,O
104271,0,(,O
104271,0,LF,O
104271,0,),O
104271,0,2145,O
104271,0,*,O
104271,0,*,O
104271,0,],O
104271,0,Chief,O
104271,0,Complaint,O
104271,0,:,O
104271,0,SOB,O
104271,0,Major,O
104271,0,Surgical,O
104271,0,or,O
104271,0,Invasive,O
104271,0,Procedure,O
104271,0,:,O
104271,0,V/Q,O
104271,0,scan,O
104271,0,CT,O
104271,0,scans,O
104271,0,TTE,O
104271,0,TEE,O
104271,0,PICC,O
104271,0,placement,O
104271,0,Bedside,O
104271,0,thoracentesis,O
104271,0,CT-guided,O
104271,0,thoracentesis,O
104271,0,Persantine,B-Drug
104271,0,cardiac,B-Reason
104271,0,stress,I-Reason
104271,0,test,I-Reason
104271,0,History,O
104271,0,of,O
104271,0,Present,O
104271,0,Illness,O
104271,0,:,O
104271,0,Pt,O
104271,0,.,O
104271,1,is,O
104271,1,a,O
104271,1,68,O
104271,1,yo,O
104271,1,active,O
104271,1,retired,O
104271,1,man,O
104271,1,with,O
104271,1,hemochromatosis,O
104271,1,",",O
104271,1,cirrhosis,O
104271,1,and,O
104271,1,DM,O
104271,1,",",O
104271,1,who,O
104271,1,had,O
104271,1,a,O
104271,1,mechanical,O
104271,1,fall,O
104271,1,2,O
104271,1,weeks,O
104271,1,prior,O
104271,1,to,O
104271,1,admission,O
104271,1,while,O
104271,1,at,O
104271,1,his,O
104271,1,winter,O
104271,1,home,O
104271,1,in,O
104271,1,[,O
104271,1,*,O
104271,1,*,O
104271,1,State,O
104271,1,108,O
104271,1,*,O
104271,1,*,O
104271,1,],O
104271,1,.,O
104271,1,After,O
104271,1,falling,O
104271,1,",",O
104271,1,he,O
104271,1,developed,O
104271,1,left,O
104271,1,sided,O
104271,1,rib,B-Reason
104271,1,pain,I-Reason
104271,1,(,O
104271,1,later,O
104271,1,found,O
104271,1,to,O
104271,1,be,O
104271,1,due,O
104271,1,to,O
104271,1,rib,O
104271,1,fracture,O
104271,1,),O
104271,1,",",O
104271,1,and,O
104271,1,sought,O
104271,1,care,O
104271,1,at,O
104271,1,the,O
104271,1,local,O
104271,1,ED,O
104271,1,",",O
104271,1,where,O
104271,1,he,O
104271,1,was,O
104271,1,told,O
104271,1,to,O
104271,1,take,O
104271,1,tylenol,B-Drug
104271,1,.,O
104271,1,After,O
104271,1,continuing,O
104271,1,to,O
104271,1,have,O
104271,1,pain,O
104271,1,for,O
104271,1,several,O
104271,1,more,O
104271,1,days,O
104271,1,he,O
104271,1,returned,O
104271,1,to,O
104271,1,the,O
104271,1,ED,O
104271,1,and,O
104271,1,was,O
104271,1,prescribed,O
104271,1,motrin,B-Drug
104271,1,for,O
104271,1,the,O
104271,1,rib,B-Reason
104271,1,pain,I-Reason
104271,1,.,O
104271,2,He,O
104271,2,reports,O
104271,2,taking,O
104271,2,600mg,O
104271,2,every,O
104271,2,4-5,O
104271,2,hrs,O
104271,2,for,O
104271,2,3-4,O
104271,2,days,O
104271,2,.,O
104271,2,He,O
104271,2,also,O
104271,2,reports,O
104271,2,having,O
104271,2,very,O
104271,2,diminished,O
104271,2,appetite,O
104271,2,and,O
104271,2,eating,O
104271,2,and,O
104271,2,drinking,O
104271,2,very,O
104271,2,little,O
104271,2,during,O
104271,2,this,O
104271,2,time,O
104271,2,.,O
104271,2,Three,O
104271,2,days,O
104271,2,PTA,O
104271,2,",",O
104271,2,he,O
104271,2,developed,O
104271,2,SOB,O
104271,2,.,O
104271,2,At,O
104271,2,the,O
104271,2,urging,O
104271,2,of,O
104271,2,his,O
104271,2,children,O
104271,2,",",O
104271,2,he,O
104271,2,flew,O
104271,2,back,O
104271,2,from,O
104271,2,FL,O
104271,2,to,O
104271,2,be,O
104271,2,seen,O
104271,2,here,O
104271,2,in,O
104271,2,[,O
104271,2,*,O
104271,2,*,O
104271,2,Location,O
104271,2,(,O
104271,2,un,O
104271,2,),O
104271,2,86,O
104271,2,*,O
104271,2,*,O
104271,2,],O
104271,2,.,O
104271,2,In,O
104271,2,addition,O
104271,2,to,O
104271,2,decreased,O
104271,2,PO,O
104271,2,intake,O
104271,2,",",O
104271,2,he,O
104271,2,reported,O
104271,2,insomnia,O
104271,2,and,O
104271,2,nausea/dry,O
104271,2,heaves,O
104271,2,.,O
104271,3,He,O
104271,3,denied,O
104271,3,abdominal,O
104271,3,pain,O
104271,3,",",O
104271,3,fevers,O
104271,3,",",O
104271,3,chills,O
104271,3,",",O
104271,3,sick,O
104271,3,contacts,O
104271,3,",",O
104271,3,or,O
104271,3,travel,O
104271,3,out,O
104271,3,of,O
104271,3,the,O
104271,3,country,O
104271,3,.,O
104271,3,.,O
104271,3,On,O
104271,3,admission,O
104271,3,",",O
104271,3,EKG,O
104271,3,showed,O
104271,3,right,O
104271,3,heart,O
104271,3,strain,O
104271,3,and,O
104271,3,possible,O
104271,3,lateral,O
104271,3,ischemic,O
104271,3,changes,O
104271,3,.,O
104271,3,Pulmonary,O
104271,3,embolism,O
104271,3,was,O
104271,3,considered,O
104271,3,;,O
104271,3,V/Q,O
104271,3,scan,O
104271,3,was,O
104271,3,read,O
104271,3,as,O
104271,3,low,O
104271,3,probability,O
104271,3,.,O
104271,3,Acute,O
104271,3,coronary,O
104271,3,syndrome,O
104271,3,was,O
104271,3,also,O
104271,3,considered,O
104271,3,",",O
104271,3,and,O
104271,3,cardiac,O
104271,3,enzymes,O
104271,3,were,O
104271,3,elevated,O
104271,3,with,O
104271,3,troponin,O
104271,3,0.12,O
104271,3,and,O
104271,3,MB,O
104271,3,index,O
104271,3,14.8,O
104271,3,.,O
104271,3,Heparin,B-Drug
104271,3,gtt,O
104271,3,was,O
104271,3,started,O
104271,3,",",O
104271,3,along,O
104271,3,with,O
104271,3,ASA,B-Drug
104271,3,and,O
104271,3,beta,B-Drug
104271,3,blocker,I-Drug
104271,3,.,O
104271,4,Also,O
104271,4,on,O
104271,4,admission,O
104271,4,",",O
104271,4,he,O
104271,4,was,O
104271,4,found,O
104271,4,to,O
104271,4,have,O
104271,4,lactic,O
104271,4,acidosis,O
104271,4,in,O
104271,4,setting,O
104271,4,of,O
104271,4,ARF,O
104271,4,(,O
104271,4,creatinine,O
104271,4,3.4,O
104271,4,with,O
104271,4,baseline,O
104271,4,1.1,O
104271,4,),O
104271,4,with,O
104271,4,serum,O
104271,4,lactate,O
104271,4,3.9,O
104271,4,--,O
104271,4,>,O
104271,4,6.7,O
104271,4,and,O
104271,4,Anion,O
104271,4,Gap,O
104271,4,of,O
104271,4,25,O
104271,4,.,O
104271,4,Serum,O
104271,4,potassium,O
104271,4,was,O
104271,4,6.0,O
104271,4,and,O
104271,4,bicarb,O
104271,4,12,O
104271,4,.,O
104271,4,He,O
104271,4,was,O
104271,4,given,O
104271,4,bicarb,B-Drug
104271,4,gtt,O
104271,4,for,O
104271,4,acidosis,B-Reason
104271,4,and,O
104271,4,kayexelate,B-Drug
104271,4,",",O
104271,4,insulin,B-Drug
104271,4,and,O
104271,4,glucose,B-Drug
104271,4,for,O
104271,4,elevated,B-Reason
104271,4,K,I-Reason
104271,4,.,O
104271,4,.,O
104271,4,Initial,O
104271,4,temp,O
104271,4,was,O
104271,4,94.4,O
104271,4,and,O
104271,4,CXR,O
104271,4,showed,O
104271,4,vague,B-Reason
104271,4,opacity,I-Reason
104271,4,in,I-Reason
104271,4,RML,I-Reason
104271,4,.,O
104271,4,Blood,O
104271,4,cultures,O
104271,4,were,O
104271,4,drawn,O
104271,4,and,O
104271,4,levo,B-Drug
104271,4,/,O
104271,4,vanc,B-Drug
104271,4,started,O
104271,4,.,O
104271,5,In,O
104271,5,the,O
104271,5,ED,O
104271,5,",",O
104271,5,patient,O
104271,5,has,O
104271,5,2,O
104271,5,transient,O
104271,5,episodes,O
104271,5,of,O
104271,5,hypotension,O
104271,5,which,O
104271,5,resolved,O
104271,5,spontaneously,O
104271,5,.,O
104271,5,He,O
104271,5,was,O
104271,5,admitted,O
104271,5,to,O
104271,5,the,O
104271,5,MICU,O
104271,5,.,O
104271,5,Past,O
104271,5,Medical,O
104271,5,History,O
104271,5,:,O
104271,5,PMH,O
104271,5,:,O
104271,5,*,O
104271,5,Hemochromatosis,O
104271,5,with,O
104271,5,monthly,O
104271,5,phlebotomy,O
104271,5,;,O
104271,5,dx,O
104271,5,15,O
104271,5,yrs,O
104271,5,ago,O
104271,5,*,O
104271,5,Cardiac,O
104271,5,involvement,O
104271,5,from,O
104271,5,hemochromatosis,O
104271,5,*,O
104271,5,DM,O
104271,5,*,O
104271,5,hx,O
104271,5,of,O
104271,5,colon,O
104271,5,polyps,O
104271,5,*,O
104271,5,gallstones,O
104271,5,(,O
104271,5,asx,O
104271,5,),O
104271,5,*,O
104271,5,Hypothyroidism,O
104271,5,*,O
104271,5,ARF,B-ADE
104271,5,in,O
104271,5,setting,O
104271,5,of,O
104271,5,NSAID,B-Drug
104271,5,use,O
104271,5,13,O
104271,5,years,O
104271,5,ago,O
104271,5,",",O
104271,5,requiring,O
104271,5,5,O
104271,5,months,O
104271,5,of,O
104271,5,HD,O
104271,5,.,O
104271,5,Social,O
104271,5,History,O
104271,5,:,O
104271,5,Widowed,O
104271,5,",",O
104271,5,occ,O
104271,5,alcohol,O
104271,5,",",O
104271,5,no,O
104271,5,cigarettes,O
104271,5,Family,O
104271,5,History,O
104271,5,:,O
104271,5,Parents,O
104271,5,died,O
104271,5,in,O
104271,5,their,O
104271,5,50s,O
104271,5,",",O
104271,5,unknown,O
104271,5,cause,O
104271,5,Physical,O
104271,5,Exam,O
104271,5,:,O
104271,5,VS,O
104271,5,:,O
104271,6,T,O
104271,6,95.2,O
104271,6,BP,O
104271,6,132/43,O
104271,6,HR,O
104271,6,74,O
104271,6,RR,O
104271,6,15,O
104271,6,O2sat,O
104271,6,100,O
104271,6,%,O
104271,6,NRB,O
104271,6,GEN,O
104271,6,:,O
104271,6,NAD,O
104271,6,",",O
104271,6,pleasant,O
104271,6,HEENT,O
104271,6,:,O
104271,6,PERRL,O
104271,6,",",O
104271,6,EOMI,O
104271,6,",",O
104271,6,no,O
104271,6,scleral,O
104271,6,icterus,O
104271,6,",",O
104271,6,MM,O
104271,6,dry,O
104271,6,NECK,O
104271,6,:,O
104271,6,JVP,O
104271,6,flat,O
104271,6,",",O
104271,6,no,O
104271,6,LAD,O
104271,6,CHEST,O
104271,6,:,O
104271,6,gynecomastia,O
104271,6,",",O
104271,6,decreased,O
104271,6,breath,O
104271,6,sounds,O
104271,6,at,O
104271,6,the,O
104271,6,bases,O
104271,6,",",O
104271,6,no,O
104271,6,wheezes,O
104271,6,",",O
104271,6,no,O
104271,6,crackles,O
104271,6,CV,O
104271,6,:,O
104271,6,Distant,O
104271,6,heart,O
104271,6,sounds,O
104271,6,",",O
104271,6,RRR,O
104271,6,",",O
104271,6,No,O
104271,6,m/r/g,O
104271,6,ABD,O
104271,6,:,O
104271,6,Normal,O
104271,6,bowel,O
104271,6,sounds,O
104271,6,",",O
104271,6,soft,O
104271,6,",",O
104271,6,nontender,O
104271,6,",",O
104271,6,no,O
104271,6,hepatomegaly,O
104271,6,EXT,O
104271,6,:,O
104271,6,bilateral,O
104271,6,2+,O
104271,6,pitting,O
104271,6,edema,O
104271,6,",",O
104271,6,flat,O
104271,6,maculopapular,O
104271,6,rash,O
104271,6,on,O
104271,6,left,O
104271,6,foot,O
104271,6,",",O
104271,6,2+DP,O
104271,6,bilaterally,O
104271,6,NRO,O
104271,6,:,O
104271,6,CN,O
104271,6,2-12,O
104271,6,intact,O
104271,6,",",O
104271,6,5/5,O
104271,6,strength,O
104271,6,throughout,O
104271,6,Pertinent,O
104271,7,Results,O
104271,7,:,O
104271,7,LABS,O
104271,7,ON,O
104271,7,ADMISSION,O
104271,7,[,O
104271,7,*,O
104271,7,*,O
104271,7,2143-1-7,O
104271,7,*,O
104271,7,*,O
104271,7,],O
104271,7,:,O
104271,7,.,O
104271,7,WBC-16.3,O
104271,7,*,O
104271,7,#,O
104271,7,RBC-4.63,O
104271,7,HGB-13.8,O
104271,7,*,O
104271,7,HCT-39.5,O
104271,7,*,O
104271,7,PLT,O
104271,7,COUNT-131,O
104271,7,*,O
104271,7,MCV-85,O
104271,7,MCH-29.7,O
104271,7,MCHC-34.8,O
104271,7,RDW-16.6,O
104271,7,*,O
104271,7,NEUTS-92.6,O
104271,7,*,O
104271,7,LYMPHS-4.4,O
104271,7,*,O
104271,7,MONOS-2.9,O
104271,7,EOS-0,O
104271,7,BASOS-0.1,O
104271,7,.,O
104271,7,SODIUM-130,O
104271,7,*,O
104271,7,CHLORIDE-92,O
104271,7,*,O
104271,7,TOTAL,O
104271,7,CO2-13,O
104271,7,*,O
104271,7,GLUCOSE-291,O
104271,7,*,O
104271,7,UREA,O
104271,7,N-52,O
104271,7,*,O
104271,7,CREAT-3.2,O
104271,7,*,O
104271,7,#,O
104271,7,SODIUM-129,O
104271,7,*,O
104271,7,POTASSIUM-5.4,O
104271,7,*,O
104271,7,CHLORIDE-93,O
104271,7,*,O
104271,7,TOTAL,O
104271,7,CO2-14,O
104271,7,*,O
104271,7,ANION,O
104271,7,GAP-27,O
104271,7,*,O
104271,7,LACTATE-6.7,O
104271,7,*,O
104271,7,.,O
104271,7,ALT,O
104271,7,(,O
104271,7,SGPT,O
104271,7,),O
104271,7,-21,O
104271,7,AST,O
104271,7,(,O
104271,7,SGOT,O
104271,7,),O
104271,7,-37,O
104271,7,CK,O
104271,7,(,O
104271,7,CPK,O
104271,7,),O
104271,7,-122,O
104271,7,ALK,O
104271,7,PHOS-156,O
104271,7,*,O
104271,7,AMYLASE-265,O
104271,7,*,O
104271,7,TOT,O
104271,7,BILI-1.1,O
104271,7,LIPASE-12,O
104271,7,ALBUMIN-2.6,O
104271,7,*,O
104271,7,.,O
104271,8,CK-MB-18,O
104271,8,*,O
104271,8,MB,O
104271,8,INDX-14.8,O
104271,8,*,O
104271,8,cTropnT-0.12,O
104271,8,*,O
104271,8,.,O
104271,8,URINE,O
104271,8,BLOOD-LG,O
104271,8,NITRITE-NEG,O
104271,8,PROTEIN-500,O
104271,8,GLUCOSE-NEG,O
104271,8,KETONE-NEG,O
104271,8,BILIRUBIN-NEG,O
104271,8,UROBILNGN-NEG,O
104271,8,PH-7.0,O
104271,8,LEUK-MOD,O
104271,8,URINE,O
104271,8,RBC-0-2,O
104271,8,WBC-,O
104271,8,[,O
104271,8,*,O
104271,8,*,O
104271,8,5-25,O
104271,8,*,O
104271,8,*,O
104271,8,],O
104271,8,*,O
104271,8,BACTERIA-NONE,O
104271,8,YEAST-NONE,O
104271,8,EPI-0,O
104271,8,URINE,O
104271,8,HOURS-RANDOM,O
104271,8,UREA,O
104271,8,N-247,O
104271,8,CREAT-178,O
104271,8,SODIUM-49,O
104271,8,POTASSIUM-38,O
104271,8,URINE,O
104271,8,OSMOLAL-358,O
104271,8,.,O
104271,8,TYPE-ART,O
104271,8,PO2-74,O
104271,8,*,O
104271,8,PCO2-29,O
104271,8,*,O
104271,8,PH-7.35,O
104271,8,TOTAL,O
104271,8,CO2-17,O
104271,8,*,O
104271,8,BASE,O
104271,8,XS,O
104271,8,--,O
104271,8,7,O
104271,8,.,O
104271,8,.,O
104271,8,STUDIES,O
104271,8,:,O
104271,8,.,O
104271,8,#,O
104271,8,.,O
104271,8,V/Q,O
104271,8,scan,O
104271,8,[,O
104271,8,*,O
104271,8,*,O
104271,8,2143-1-7,O
104271,8,*,O
104271,8,*,O
104271,8,],O
104271,8,INTERPRETATION,O
104271,8,:,O
104271,8,Ventilation,O
104271,8,images,O
104271,8,obtained,O
104271,8,with,O
104271,8,Tc-,O
104271,8,[,O
104271,8,*,O
104271,8,*,O
104271,8,Age,O
104271,8,over,O
104271,8,90,O
104271,8,*,O
104271,8,*,O
104271,8,],O
104271,8,m,O
104271,8,aerosol,O
104271,8,in,O
104271,8,8,O
104271,8,views,O
104271,8,demonstrate,O
104271,8,very,O
104271,8,heterogenous,O
104271,8,ventilation,O
104271,8,with,O
104271,8,numerous,O
104271,8,subsegmental,O
104271,8,defects,O
104271,9,bilaterally,O
104271,9,.,O
104271,9,Perfusion,O
104271,9,images,O
104271,9,in,O
104271,9,the,O
104271,9,same,O
104271,9,8,O
104271,9,views,O
104271,9,show,O
104271,9,numerous,O
104271,9,small,O
104271,9,bilateral,O
104271,9,non-segmental,O
104271,9,defects,O
104271,9,.,O
104271,9,These,O
104271,9,defects,O
104271,9,are,O
104271,9,in,O
104271,9,the,O
104271,9,same,O
104271,9,areas,O
104271,9,as,O
104271,9,the,O
104271,9,ventilation,O
104271,9,defects,O
104271,9,",",O
104271,9,but,O
104271,9,are,O
104271,9,less,O
104271,9,prominent,O
104271,9,.,O
104271,9,The,O
104271,9,AP,O
104271,9,dimension,O
104271,9,is,O
104271,9,enlarged,O
104271,9,",",O
104271,9,and,O
104271,9,the,O
104271,9,diaphgrams,O
104271,9,are,O
104271,9,flattened,O
104271,9,.,O
104271,9,The,O
104271,9,chest,O
104271,9,x-ray,O
104271,9,is,O
104271,9,clear,O
104271,9,.,O
104271,9,The,O
104271,9,above,O
104271,9,findings,O
104271,9,are,O
104271,9,consistent,O
104271,9,with,O
104271,9,a,O
104271,9,low,O
104271,9,probability,O
104271,9,for,O
104271,9,pulmonary,O
104271,9,embolism,O
104271,9,",",O
104271,9,but,O
104271,9,are,O
104271,9,consistent,O
104271,9,with,O
104271,9,COPD,O
104271,9,.,O
104271,9,.,O
104271,9,#,O
104271,9,.,O
104271,9,TTE,O
104271,9,[,O
104271,9,*,O
104271,9,*,O
104271,9,2143-1-8,O
104271,9,*,O
104271,9,*,O
104271,9,],O
104271,9,Conclusions,O
104271,9,:,O
104271,9,The,O
104271,9,left,O
104271,9,atrium,O
104271,9,is,O
104271,9,elongated,O
104271,9,.,O
104271,10,The,O
104271,10,right,O
104271,10,atrium,O
104271,10,is,O
104271,10,moderately,O
104271,10,dilated,O
104271,10,.,O
104271,10,There,O
104271,10,is,O
104271,10,mild,O
104271,10,symmetric,O
104271,10,left,O
104271,10,ventricular,O
104271,10,hypertrophy,O
104271,10,with,O
104271,10,normal,O
104271,10,cavity,O
104271,10,size,O
104271,10,and,O
104271,10,systolic,O
104271,10,function,O
104271,10,(,O
104271,10,LVEF,O
104271,10,>,O
104271,10,55,O
104271,10,%,O
104271,10,),O
104271,10,.,O
104271,10,Due,O
104271,10,to,O
104271,10,suboptimal,O
104271,10,technical,O
104271,10,quality,O
104271,10,",",O
104271,10,a,O
104271,10,focal,O
104271,10,wall,O
104271,10,motion,O
104271,10,abnormality,O
104271,10,can,O
104271,10,not,O
104271,10,be,O
104271,10,fully,O
104271,10,excluded,O
104271,10,.,O
104271,10,The,O
104271,10,right,O
104271,10,ventricular,O
104271,10,cavity,O
104271,10,is,O
104271,10,moderately,O
104271,10,dilated,O
104271,10,with,O
104271,10,severe,O
104271,10,global,O
104271,10,free,O
104271,10,wall,O
104271,10,hypokinesis,O
104271,10,.,O
104271,10,There,O
104271,10,is,O
104271,10,abnormal,O
104271,10,septal,O
104271,10,motion/position,O
104271,10,consistent,O
104271,10,with,O
104271,10,right,O
104271,10,ventricular,O
104271,10,pressure/volume,O
104271,10,overload,O
104271,10,.,O
104271,10,The,O
104271,10,aortic,O
104271,10,valve,O
104271,10,leaflets,O
104271,10,(,O
104271,10,3,O
104271,10,),O
104271,10,are,O
104271,10,mildly,O
104271,10,thickened,O
104271,10,but,O
104271,10,aortic,O
104271,10,stenosis,O
104271,10,is,O
104271,10,not,O
104271,10,present,O
104271,10,.,O
104271,11,No,O
104271,11,aortic,O
104271,11,regurgitation,O
104271,11,is,O
104271,11,seen,O
104271,11,.,O
104271,11,The,O
104271,11,mitral,O
104271,11,valve,O
104271,11,leaflets,O
104271,11,are,O
104271,11,structurally,O
104271,11,normal,O
104271,11,.,O
104271,11,Mild,O
104271,11,(,O
104271,11,1+,O
104271,11,),O
104271,11,mitral,O
104271,11,regurgitation,O
104271,11,is,O
104271,11,seen,O
104271,11,.,O
104271,11,There,O
104271,11,is,O
104271,11,moderate,O
104271,11,to,O
104271,11,severe,O
104271,11,pulmonary,O
104271,11,artery,O
104271,11,systolic,O
104271,11,hypertension,O
104271,11,.,O
104271,11,There,O
104271,11,is,O
104271,11,no,O
104271,11,pericardial,O
104271,11,effusion,O
104271,11,.,O
104271,11,IMPRESSION,O
104271,11,:,O
104271,11,Mild,O
104271,11,symmetric,O
104271,11,left,O
104271,11,ventricular,O
104271,11,hypertrophy,O
104271,11,with,O
104271,11,preserved,O
104271,11,global,O
104271,11,systolic,O
104271,11,function,O
104271,11,.,O
104271,11,Right,O
104271,11,ventricular,O
104271,11,cavity,O
104271,11,enlargement,O
104271,11,with,O
104271,11,free,O
104271,11,wall,O
104271,11,hypokinesis,O
104271,11,and,O
104271,11,moderate-severe,O
104271,11,pulmonary,O
104271,11,artery,O
104271,11,systolic,O
104271,11,hypertension,O
104271,11,c/w,O
104271,11,a,O
104271,11,primary,O
104271,11,pulmonary,O
104271,11,process,O
104271,11,.,O
104271,11,.,O
104271,11,#,O
104271,11,.,O
104271,11,ECG,O
104271,11,[,O
104271,11,*,O
104271,11,*,O
104271,11,2143-1-9,O
104271,11,*,O
104271,11,*,O
104271,11,],O
104271,11,Sinus,O
104271,11,rhythm,O
104271,11,",",O
104271,11,right,O
104271,11,ventricular,O
104271,11,hypertrophy,O
104271,11,",",O
104271,11,Diffuse,O
104271,11,ST-T,O
104271,11,wave,O
104271,11,changes,O
104271,11,with,O
104271,11,borderline,O
104271,11,prolonged/upper,O
104271,11,limits,O
104271,11,of,O
104271,11,normal,O
104271,12,Q-Tc,O
104271,12,interval,O
104271,12,-,O
104271,12,could,O
104271,12,be,O
104271,12,due,O
104271,12,in,O
104271,12,part,O
104271,12,to,O
104271,12,right,O
104271,12,ventricular,O
104271,12,hypertrophy,O
104271,12,but,O
104271,12,clinical,O
104271,12,correlation,O
104271,12,is,O
104271,12,suggested,O
104271,12,Since,O
104271,12,previous,O
104271,12,tracing,O
104271,12,of,O
104271,12,[,O
104271,12,*,O
104271,12,*,O
104271,12,2143-1-8,O
104271,12,*,O
104271,12,*,O
104271,12,],O
104271,12,",",O
104271,12,further,O
104271,12,ST-T,O
104271,12,wave,O
104271,12,changes,O
104271,12,present,O
104271,12,and,O
104271,12,Q-Tc,O
104271,12,interval,O
104271,12,appears,O
104271,12,short,O
104271,12,.,O
104271,12,.,O
104271,12,#,O
104271,12,.,O
104271,12,CT,O
104271,12,chest,O
104271,12,with,O
104271,12,Contrast,O
104271,12,[,O
104271,12,*,O
104271,12,*,O
104271,12,2143-1-9,O
104271,12,*,O
104271,12,*,O
104271,12,],O
104271,12,IMPRESSION,O
104271,12,:,O
104271,12,1,O
104271,12,.,O
104271,12,Right,O
104271,12,loculated,O
104271,12,collection,O
104271,12,which,O
104271,12,has,O
104271,12,high,O
104271,12,CT,O
104271,12,attenuation,O
104271,12,value,O
104271,12,and,O
104271,12,may,O
104271,12,represent,O
104271,12,either,O
104271,12,empyema,O
104271,12,or,O
104271,12,hemorrhage,O
104271,12,within,O
104271,12,pleural,O
104271,12,effusion,O
104271,12,.,O
104271,13,2,O
104271,13,.,O
104271,13,Right,O
104271,13,lower,O
104271,13,lobe,O
104271,13,opacity,O
104271,13,with,O
104271,13,bronchial,O
104271,13,wall,O
104271,13,thickening,O
104271,13,which,O
104271,13,may,O
104271,13,represent,O
104271,13,pneumonia/aspiration,O
104271,13,.,O
104271,13,3,O
104271,13,.,O
104271,13,Right,O
104271,13,basilar,O
104271,13,atelectasis,O
104271,13,.,O
104271,13,4,O
104271,13,.,O
104271,13,Small,O
104271,13,left,O
104271,13,pleural,O
104271,13,effusion,O
104271,13,.,O
104271,13,5,O
104271,13,.,O
104271,13,Ground-glass,O
104271,13,opacity,O
104271,13,in,O
104271,13,the,O
104271,13,right,O
104271,13,apex,O
104271,13,.,O
104271,13,This,O
104271,13,should,O
104271,13,be,O
104271,13,followed,O
104271,13,up,O
104271,13,with,O
104271,13,a,O
104271,13,CT,O
104271,13,in,O
104271,13,three,O
104271,13,months,O
104271,13,.,O
104271,13,6,O
104271,13,.,O
104271,13,Focal,O
104271,13,ground-glass,O
104271,13,opacity,O
104271,13,in,O
104271,13,the,O
104271,13,right,O
104271,13,middle,O
104271,13,lobe,O
104271,13,and,O
104271,13,right,O
104271,13,lower,O
104271,13,lobe,O
104271,13,may,O
104271,13,represent,O
104271,13,infectious/inflammatory,O
104271,13,etiology,O
104271,13,.,O
104271,13,This,O
104271,13,could,O
104271,13,also,O
104271,13,be,O
104271,13,followed,O
104271,13,up,O
104271,13,on,O
104271,13,the,O
104271,13,CT,O
104271,13,which,O
104271,13,will,O
104271,13,be,O
104271,13,obtained,O
104271,13,in,O
104271,13,three,O
104271,13,months,O
104271,13,.,O
104271,14,7,O
104271,14,.,O
104271,14,Atherosclerotic,O
104271,14,coronary,O
104271,14,calcifications,O
104271,14,.,O
104271,14,8,O
104271,14,.,O
104271,14,Gallstones,O
104271,14,without,O
104271,14,evidence,O
104271,14,of,O
104271,14,cholecystitis,O
104271,14,.,O
104271,14,9,O
104271,14,.,O
104271,14,Liver,O
104271,14,granulomas,O
104271,14,.,O
104271,14,.,O
104271,14,#,O
104271,14,.,O
104271,14,Renal,O
104271,14,US,O
104271,14,[,O
104271,14,*,O
104271,14,*,O
104271,14,2143-1-10,O
104271,14,*,O
104271,14,*,O
104271,14,],O
104271,14,:,O
104271,14,FINDINGS,O
104271,14,:,O
104271,14,The,O
104271,14,right,O
104271,14,kidney,O
104271,14,measures,O
104271,14,9,O
104271,14,cm,O
104271,14,in,O
104271,14,length,O
104271,14,",",O
104271,14,previously,O
104271,14,measuring,O
104271,14,9.5,O
104271,14,cm,O
104271,14,.,O
104271,14,The,O
104271,14,left,O
104271,14,kidney,O
104271,14,measures,O
104271,14,10.2,O
104271,14,cm,O
104271,14,in,O
104271,14,length,O
104271,14,",",O
104271,14,previously,O
104271,14,measuring,O
104271,14,10.7,O
104271,14,cm,O
104271,14,in,O
104271,14,length,O
104271,14,.,O
104271,14,In,O
104271,14,the,O
104271,14,interpolar,O
104271,14,region,O
104271,14,of,O
104271,14,the,O
104271,14,right,O
104271,14,kidney,O
104271,14,",",O
104271,14,there,O
104271,14,is,O
104271,14,an,O
104271,14,area,O
104271,14,with,O
104271,14,lobulated,O
104271,14,appearance,O
104271,14,consistent,O
104271,14,with,O
104271,14,cortical,O
104271,14,scarring,O
104271,14,",",O
104271,14,unchanged,O
104271,14,from,O
104271,14,the,O
104271,14,prior,O
104271,14,study,O
104271,14,.,O
104271,15,In,O
104271,15,the,O
104271,15,interpolar,O
104271,15,region,O
104271,15,of,O
104271,15,the,O
104271,15,left,O
104271,15,kidney,O
104271,15,",",O
104271,15,there,O
104271,15,is,O
104271,15,a,O
104271,15,tiny,O
104271,15,cortical,O
104271,15,crystal,O
104271,15,.,O
104271,15,There,O
104271,15,is,O
104271,15,no,O
104271,15,hydronephrosis,O
104271,15,",",O
104271,15,stones,O
104271,15,",",O
104271,15,or,O
104271,15,renal,O
104271,15,masses,O
104271,15,.,O
104271,15,There,O
104271,15,is,O
104271,15,no,O
104271,15,perirenal,O
104271,15,fluid,O
104271,15,.,O
104271,15,The,O
104271,15,bladder,O
104271,15,is,O
104271,15,unremarkable,O
104271,15,.,O
104271,15,IMPRESSION,O
104271,15,:,O
104271,15,1,O
104271,15,.,O
104271,15,Slight,O
104271,15,interval,O
104271,15,decrease,O
104271,15,in,O
104271,15,size,O
104271,15,in,O
104271,15,both,O
104271,15,kidneys,O
104271,15,.,O
104271,15,2,O
104271,15,.,O
104271,15,There,O
104271,15,is,O
104271,15,no,O
104271,15,hydronephrosis,O
104271,15,.,O
104271,15,3,O
104271,15,.,O
104271,15,Stable,O
104271,15,area,O
104271,15,of,O
104271,15,cortical,O
104271,15,scarring,O
104271,15,in,O
104271,15,the,O
104271,15,right,O
104271,15,kidney,O
104271,15,.,O
104271,15,.,O
104271,15,#,O
104271,15,.,O
104271,15,TEE,O
104271,15,[,O
104271,15,*,O
104271,15,*,O
104271,15,2143-1-15,O
104271,15,*,O
104271,15,*,O
104271,15,],O
104271,15,Conclusions,O
104271,15,:,O
104271,15,1,O
104271,15,.,O
104271,16,The,O
104271,16,left,O
104271,16,atrium,O
104271,16,is,O
104271,16,dilated,O
104271,16,.,O
104271,16,2,O
104271,16,.,O
104271,16,The,O
104271,16,left,O
104271,16,ventricular,O
104271,16,cavity,O
104271,16,size,O
104271,16,is,O
104271,16,normal,O
104271,16,.,O
104271,16,Due,O
104271,16,to,O
104271,16,suboptimal,O
104271,16,technical,O
104271,16,quality,O
104271,16,",",O
104271,16,a,O
104271,16,focal,O
104271,16,wall,O
104271,16,motion,O
104271,16,abnormality,O
104271,16,can,O
104271,16,not,O
104271,16,be,O
104271,16,fully,O
104271,16,excluded,O
104271,16,.,O
104271,16,Overall,O
104271,16,left,O
104271,16,ventricular,O
104271,16,systolic,O
104271,16,function,O
104271,16,is,O
104271,16,difficult,O
104271,16,to,O
104271,16,assess,O
104271,16,but,O
104271,16,is,O
104271,16,probably,O
104271,16,normal,O
104271,16,.,O
104271,16,3,O
104271,16,.,O
104271,16,There,O
104271,16,are,O
104271,16,complex,O
104271,16,(,O
104271,16,>,O
104271,16,4mm,O
104271,16,),O
104271,16,sessile,O
104271,16,atheroma,O
104271,16,in,O
104271,16,the,O
104271,16,aortic,O
104271,16,arch,O
104271,16,.,O
104271,16,There,O
104271,16,are,O
104271,16,simple,O
104271,16,atheroma,O
104271,16,in,O
104271,16,the,O
104271,16,descending,O
104271,16,thoracic,O
104271,16,aorta,O
104271,16,.,O
104271,16,4,O
104271,16,.,O
104271,16,The,O
104271,16,aortic,O
104271,16,valve,O
104271,16,leaflets,O
104271,16,(,O
104271,16,3,O
104271,16,),O
104271,16,are,O
104271,16,mildly,O
104271,16,thickened,O
104271,16,.,O
104271,17,No,O
104271,17,aortic,O
104271,17,regurgitation,O
104271,17,is,O
104271,17,seen,O
104271,17,.,O
104271,17,5,O
104271,17,.,O
104271,17,The,O
104271,17,mitral,O
104271,17,valve,O
104271,17,leaflets,O
104271,17,are,O
104271,17,mildly,O
104271,17,thickened,O
104271,17,.,O
104271,17,Trivial,O
104271,17,mitral,O
104271,17,regurgitation,O
104271,17,is,O
104271,17,seen,O
104271,17,.,O
104271,17,6,O
104271,17,.,O
104271,17,There,O
104271,17,is,O
104271,17,a,O
104271,17,small,O
104271,17,pericardial,O
104271,17,effusion,O
104271,17,.,O
104271,17,7,O
104271,17,.,O
104271,17,No,O
104271,17,evidence,O
104271,17,of,O
104271,17,endocarditis,O
104271,17,seen,O
104271,17,.,O
104271,17,.,O
104271,17,#,O
104271,17,.,O
104271,17,CTA,O
104271,17,Chest,O
104271,17,[,O
104271,17,*,O
104271,17,*,O
104271,17,2143-1-16,O
104271,17,*,O
104271,17,*,O
104271,17,],O
104271,17,:,O
104271,17,1,O
104271,17,.,O
104271,17,No,O
104271,17,evidence,O
104271,17,of,O
104271,17,pulmonary,O
104271,17,embolism,O
104271,17,.,O
104271,17,2,O
104271,17,.,O
104271,17,Unchanged,O
104271,17,right,O
104271,17,loculated,O
104271,17,collection,O
104271,17,within,O
104271,17,the,O
104271,17,pleural,O
104271,17,space,O
104271,17,of,O
104271,17,hyperattenuation,O
104271,17,.,O
104271,17,Given,O
104271,17,the,O
104271,17,appearance,O
104271,17,with,O
104271,17,increased,O
104271,17,subpleural,O
104271,17,fat,O
104271,17,",",O
104271,17,this,O
104271,17,has,O
104271,17,the,O
104271,17,appearance,O
104271,17,of,O
104271,17,chronic,O
104271,17,right,O
104271,17,effusion,O
104271,17,.,O
104271,18,It,O
104271,18,is,O
104271,18,difficult,O
104271,18,to,O
104271,18,comment,O
104271,18,on,O
104271,18,possible,O
104271,18,thickening,O
104271,18,of,O
104271,18,the,O
104271,18,pleura,O
104271,18,.,O
104271,18,3,O
104271,18,.,O
104271,18,Small,O
104271,18,left,O
104271,18,simple,O
104271,18,effusion,O
104271,18,",",O
104271,18,slightly,O
104271,18,increased,O
104271,18,from,O
104271,18,the,O
104271,18,prior,O
104271,18,study,O
104271,18,.,O
104271,18,4,O
104271,18,.,O
104271,18,3-mm,O
104271,18,nodule,O
104271,18,in,O
104271,18,the,O
104271,18,right,O
104271,18,middle,O
104271,18,lobe,O
104271,18,.,O
104271,18,In,O
104271,18,the,O
104271,18,absence,O
104271,18,of,O
104271,18,known,O
104271,18,malignancy,O
104271,18,",",O
104271,18,one-year,O
104271,18,CT,O
104271,18,followup,O
104271,18,could,O
104271,18,be,O
104271,18,considered,O
104271,18,.,O
104271,18,5,O
104271,18,.,O
104271,18,Atherosclerotic,O
104271,18,coronary,O
104271,18,artery,O
104271,18,calcifications,O
104271,18,.,O
104271,18,6,O
104271,18,.,O
104271,18,Cirrhosis,O
104271,18,of,O
104271,18,the,O
104271,18,liver,O
104271,18,",",O
104271,18,with,O
104271,18,low-attenuation,O
104271,18,oval,O
104271,18,lesion,O
104271,18,near,O
104271,18,the,O
104271,18,dome,O
104271,18,.,O
104271,18,It,O
104271,18,is,O
104271,18,incompletely,O
104271,18,characterized,O
104271,18,on,O
104271,18,the,O
104271,18,study,O
104271,18,.,O
104271,19,7,O
104271,19,.,O
104271,19,Gallstones,O
104271,19,without,O
104271,19,evidence,O
104271,19,of,O
104271,19,cholecystitis,O
104271,19,.,O
104271,19,8,O
104271,19,.,O
104271,19,Left,O
104271,19,lateral,O
104271,19,fifth,O
104271,19,and,O
104271,19,seventh,O
104271,19,rib,O
104271,19,fractures,O
104271,19,.,O
104271,19,9,O
104271,19,.,O
104271,19,Cystic,O
104271,19,structure,O
104271,19,above,O
104271,19,the,O
104271,19,manubrial,O
104271,19,notch,O
104271,19,without,O
104271,19,enhancement,O
104271,19,",",O
104271,19,incompletely,O
104271,19,characterized,O
104271,19,on,O
104271,19,this,O
104271,19,study,O
104271,19,.,O
104271,19,.,O
104271,19,#,O
104271,19,.,O
104271,19,Core,O
104271,19,biopsy,O
104271,19,of,O
104271,19,R,O
104271,19,solid,O
104271,19,pleural,O
104271,19,effusion,O
104271,19,[,O
104271,19,*,O
104271,19,*,O
104271,19,2143-1-17,O
104271,19,*,O
104271,19,*,O
104271,19,],O
104271,19,.,O
104271,19,#,O
104271,19,.,O
104271,19,Stress,O
104271,19,test,O
104271,19,[,O
104271,19,*,O
104271,19,*,O
104271,19,2143-1-21,O
104271,19,*,O
104271,19,*,O
104271,19,],O
104271,19,Exercising,O
104271,19,stress,O
104271,19,test,O
104271,19,:,O
104271,19,No,O
104271,19,anginal,O
104271,19,symptoms,O
104271,19,or,O
104271,19,ECG,O
104271,19,changes,O
104271,19,from,O
104271,19,baseline,O
104271,19,.,O
104271,20,N,O
104271,20,Persantine,B-Drug
104271,20,MIBI,B-Reason
104271,20,:,O
104271,20,Left,O
104271,20,ventricular,O
104271,20,cavity,O
104271,20,size,O
104271,20,is,O
104271,20,normal,O
104271,20,.,O
104271,20,Resting,O
104271,20,and,O
104271,20,stress,O
104271,20,perfusion,O
104271,20,images,O
104271,20,reveal,O
104271,20,uniform,O
104271,20,tracer,O
104271,20,uptake,O
104271,20,throughout,O
104271,20,the,O
104271,20,myocardium,O
104271,20,.,O
104271,20,Gated,O
104271,20,images,O
104271,20,reveal,O
104271,20,normal,O
104271,20,wall,O
104271,20,motion,O
104271,20,.,O
104271,20,The,O
104271,20,calculated,O
104271,20,left,O
104271,20,ventricular,O
104271,20,ejection,O
104271,20,fraction,O
104271,20,is,O
104271,20,71,O
104271,20,%,O
104271,20,.,O
104271,20,No,O
104271,20,prior,O
104271,20,studies,O
104271,20,are,O
104271,20,available,O
104271,20,for,O
104271,20,comparison,O
104271,20,.,O
104271,20,IMPRESSION,O
104271,20,:,O
104271,20,Normal,O
104271,20,myocardial,O
104271,20,perfusion,O
104271,20,.,O
104271,20,EF,O
104271,20,71,O
104271,20,%,O
104271,20,.,O
104271,20,Brief,O
104271,20,Hospital,O
104271,20,Course,O
104271,20,:,O
104271,20,#,O
104271,20,.,O
104271,20,Anion,O
104271,20,Gap,O
104271,20,Acidosis,O
104271,20,:,O
104271,20,Was,O
104271,20,likely,O
104271,20,due,O
104271,20,to,O
104271,20,lactic,O
104271,20,acidosis,O
104271,20,given,O
104271,20,his,O
104271,20,high,O
104271,20,lactate,O
104271,20,on,O
104271,20,admission,O
104271,20,.,O
104271,21,High,O
104271,21,lactate,O
104271,21,production,O
104271,21,likely,O
104271,21,occurred,O
104271,21,[,O
104271,21,*,O
104271,21,*,O
104271,21,1-17,O
104271,21,*,O
104271,21,*,O
104271,21,],O
104271,21,sepsis,O
104271,21,and,O
104271,21,poor,O
104271,21,perfusion,O
104271,21,",",O
104271,21,and,O
104271,21,ARF,O
104271,21,prevented,O
104271,21,clearance,O
104271,21,of,O
104271,21,lactate,O
104271,21,.,O
104271,21,Was,O
104271,21,treated,O
104271,21,with,O
104271,21,bicarb,O
104271,21,in,O
104271,21,the,O
104271,21,ED,O
104271,21,and,O
104271,21,Gap,O
104271,21,resolved,O
104271,21,.,O
104271,21,.,O
104271,21,#,O
104271,21,.,O
104271,21,Hyperkalemia,B-Reason
104271,21,:,O
104271,21,resolved,O
104271,21,after,O
104271,21,receiving,O
104271,21,kayexelate,B-Drug
104271,21,",",O
104271,21,insulin,B-Drug
104271,21,and,O
104271,21,glucose,B-Drug
104271,21,in,O
104271,21,ED,O
104271,21,.,O
104271,21,.,O
104271,21,#,O
104271,21,.,O
104271,21,RV,O
104271,21,strain/Pulmonary,O
104271,21,Hypertension,O
104271,21,:,O
104271,21,On,O
104271,21,[,O
104271,21,*,O
104271,21,*,O
104271,21,1-8,O
104271,21,*,O
104271,21,*,O
104271,21,],O
104271,21,TTE,O
104271,21,was,O
104271,21,obtained,O
104271,21,and,O
104271,21,showed,O
104271,21,a,O
104271,21,dilated,O
104271,21,RV,O
104271,21,with,O
104271,21,severe,O
104271,21,global,O
104271,21,free,O
104271,21,wall,O
104271,21,hypokinesis,O
104271,21,and,O
104271,21,abnormal,O
104271,21,septal,O
104271,21,movement,O
104271,21,.,O
104271,22,He,O
104271,22,was,O
104271,22,also,O
104271,22,noted,O
104271,22,to,O
104271,22,have,O
104271,22,moderate-severe,O
104271,22,pulmonary,O
104271,22,artery,O
104271,22,systolic,O
104271,22,hypertension,O
104271,22,consistent,O
104271,22,with,O
104271,22,a,O
104271,22,primary,O
104271,22,pulmonary,O
104271,22,process,O
104271,22,.,O
104271,22,LVEF,O
104271,22,was,O
104271,22,>,O
104271,22,55,O
104271,22,%,O
104271,22,.,O
104271,22,Elevated,O
104271,22,tropinins,O
104271,22,measured,O
104271,22,in,O
104271,22,the,O
104271,22,ED,O
104271,22,were,O
104271,22,thought,O
104271,22,to,O
104271,22,be,O
104271,22,due,O
104271,22,to,O
104271,22,RV,O
104271,22,strain,O
104271,22,combined,O
104271,22,with,O
104271,22,decreased,O
104271,22,renal,O
104271,22,clearance,O
104271,22,.,O
104271,22,By,O
104271,22,[,O
104271,22,*,O
104271,22,*,O
104271,22,1-9,O
104271,22,*,O
104271,22,*,O
104271,22,],O
104271,22,",",O
104271,22,troponin,O
104271,22,had,O
104271,22,trended,O
104271,22,down,O
104271,22,and,O
104271,22,heparin,B-Drug
104271,22,gtt,O
104271,22,was,O
104271,22,discontinued,O
104271,22,.,O
104271,22,For,O
104271,22,his,O
104271,22,pulmonary,O
104271,22,hypertension,O
104271,22,observed,O
104271,22,on,O
104271,22,echo,O
104271,22,",",O
104271,22,a,O
104271,22,pulmonary,O
104271,22,consult,O
104271,22,was,O
104271,22,obtained,O
104271,22,.,O
104271,23,Acute,O
104271,23,PE,O
104271,23,was,O
104271,23,thought,O
104271,23,to,O
104271,23,be,O
104271,23,an,O
104271,23,unlikely,O
104271,23,cause,O
104271,23,of,O
104271,23,his,O
104271,23,echo,O
104271,23,findings,O
104271,23,given,O
104271,23,the,O
104271,23,negative,O
104271,23,V/Q,O
104271,23,scan,O
104271,23,on,O
104271,23,admission,O
104271,23,",",O
104271,23,but,O
104271,23,chronic,O
104271,23,PE,O
104271,23,was,O
104271,23,thought,O
104271,23,to,O
104271,23,be,O
104271,23,a,O
104271,23,possibility,O
104271,23,.,O
104271,23,CTA,O
104271,23,was,O
104271,23,obtained,O
104271,23,on,O
104271,23,[,O
104271,23,*,O
104271,23,*,O
104271,23,1-16,O
104271,23,*,O
104271,23,*,O
104271,23,],O
104271,23,",",O
104271,23,which,O
104271,23,was,O
104271,23,negative,O
104271,23,.,O
104271,23,Other,O
104271,23,etiologies,O
104271,23,were,O
104271,23,considered,O
104271,23,",",O
104271,23,including,O
104271,23,porto-pulmonary,O
104271,23,hypertension,O
104271,23,from,O
104271,23,cirrhosis,O
104271,23,.,O
104271,23,HIV,O
104271,23,",",O
104271,23,[,O
104271,23,*,O
104271,23,*,O
104271,23,Doctor,O
104271,23,First,O
104271,23,Name,O
104271,23,*,O
104271,23,*,O
104271,23,],O
104271,23,and,O
104271,23,RF,O
104271,23,were,O
104271,23,sent,O
104271,23,and,O
104271,23,found,O
104271,23,to,O
104271,23,be,O
104271,23,negative,O
104271,23,.,O
104271,24,Scleroderma,O
104271,24,antibody,O
104271,24,test,O
104271,24,is,O
104271,24,pending,O
104271,24,.,O
104271,24,He,O
104271,24,will,O
104271,24,undergo,O
104271,24,an,O
104271,24,outpatient,O
104271,24,work-up,O
104271,24,for,O
104271,24,pulmonary,O
104271,24,hypertension,O
104271,24,with,O
104271,24,PFTs,O
104271,24,",",O
104271,24,sleep,O
104271,24,study,O
104271,24,",",O
104271,24,and,O
104271,24,outpatient,O
104271,24,appointment,O
104271,24,with,O
104271,24,Dr.,O
104271,24,[,O
104271,24,*,O
104271,24,*,O
104271,24,First,O
104271,24,Name4,O
104271,24,(,O
104271,24,NamePattern1,O
104271,24,),O
104271,24,*,O
104271,24,*,O
104271,24,],O
104271,24,[,O
104271,24,*,O
104271,24,*,O
104271,24,Last,O
104271,24,Name,O
104271,24,(,O
104271,24,NamePattern1,O
104271,24,),O
104271,24,*,O
104271,24,*,O
104271,24,],O
104271,24,.,O
104271,24,.,O
104271,24,#,O
104271,24,.,O
104271,24,Hypoxia,B-Reason
104271,24,:,O
104271,24,The,O
104271,24,patient,O
104271,24,was,O
104271,24,dyspneic,O
104271,24,on,O
104271,24,admission,O
104271,24,",",O
104271,24,and,O
104271,24,was,O
104271,24,maintained,O
104271,24,on,O
104271,24,supplemental,O
104271,24,oxygen,B-Drug
104271,24,for,O
104271,24,oxygen,O
104271,24,saturations,O
104271,24,that,O
104271,24,dropped,O
104271,24,into,O
104271,24,the,O
104271,24,high,O
104271,24,80,O
104271,24,'s,O
104271,24,at,O
104271,24,rest,O
104271,24,on,O
104271,24,room,O
104271,24,air,O
104271,24,.,O
104271,25,This,O
104271,25,was,O
104271,25,thought,O
104271,25,to,O
104271,25,be,O
104271,25,related,O
104271,25,to,O
104271,25,a,O
104271,25,presumed,O
104271,25,RML,O
104271,25,pneumonia,O
104271,25,(,O
104271,25,seen,O
104271,25,as,O
104271,25,opacity,O
104271,25,on,O
104271,25,admission,O
104271,25,CXR,O
104271,25,),O
104271,25,and,O
104271,25,underlying,O
104271,25,pulmonary,O
104271,25,hypertension,O
104271,25,seen,O
104271,25,on,O
104271,25,Echo,O
104271,25,.,O
104271,25,However,O
104271,25,",",O
104271,25,the,O
104271,25,opacity,O
104271,25,observed,O
104271,25,on,O
104271,25,CXR,O
104271,25,was,O
104271,25,not,O
104271,25,seen,O
104271,25,on,O
104271,25,CT,O
104271,25,from,O
104271,25,[,O
104271,25,*,O
104271,25,*,O
104271,25,1-16,O
104271,25,*,O
104271,25,*,O
104271,25,],O
104271,25,",",O
104271,25,so,O
104271,25,it,O
104271,25,is,O
104271,25,unlikely,O
104271,25,that,O
104271,25,the,O
104271,25,original,O
104271,25,opacity,O
104271,25,represented,O
104271,25,a,O
104271,25,pneumonia,O
104271,25,as,O
104271,25,originally,O
104271,25,thought,O
104271,25,.,O
104271,25,His,O
104271,25,dyspnea,O
104271,25,slowly,O
104271,25,improved,O
104271,25,",",O
104271,25,and,O
104271,25,he,O
104271,25,was,O
104271,25,weaned,O
104271,25,from,O
104271,25,supplemental,O
104271,25,oxygen,B-Drug
104271,25,by,O
104271,25,[,O
104271,25,*,O
104271,25,*,O
104271,25,1-14,O
104271,25,*,O
104271,25,*,O
104271,25,],O
104271,25,.,O
104271,26,However,O
104271,26,",",O
104271,26,on,O
104271,26,[,O
104271,26,*,O
104271,26,*,O
104271,26,1-15,O
104271,26,*,O
104271,26,*,O
104271,26,],O
104271,26,he,O
104271,26,again,O
104271,26,developed,O
104271,26,an,O
104271,26,oxygen,B-Drug
104271,26,requirement,O
104271,26,after,O
104271,26,IV,O
104271,26,fluids,B-Drug
104271,26,were,O
104271,26,initiated,O
104271,26,in,O
104271,26,preparation,O
104271,26,for,O
104271,26,receiving,O
104271,26,IV,O
104271,26,contrast,B-Drug
104271,26,",",O
104271,26,and,O
104271,26,on,O
104271,26,[,O
104271,26,*,O
104271,26,*,O
104271,26,1-16,O
104271,26,*,O
104271,26,*,O
104271,26,],O
104271,26,",",O
104271,26,resting,O
104271,26,oxygen,O
104271,26,saturation,O
104271,26,was,O
104271,26,measured,O
104271,26,at,O
104271,26,89,O
104271,26,%,O
104271,26,on,O
104271,26,room,O
104271,26,air,O
104271,26,at,O
104271,26,rest,O
104271,26,",",O
104271,26,85,O
104271,26,%,O
104271,26,while,O
104271,26,ambulating,O
104271,26,.,O
104271,26,CTA,O
104271,26,[,O
104271,26,*,O
104271,26,*,O
104271,26,1-16,O
104271,26,*,O
104271,26,*,O
104271,26,],O
104271,26,showed,O
104271,26,an,O
104271,26,enlarged,O
104271,26,left-sided,O
104271,26,pleural,O
104271,26,effusion,O
104271,26,(,O
104271,26,fluid,O
104271,26,density,O
104271,26,),O
104271,26,and,O
104271,26,a,O
104271,26,R-sided,O
104271,26,pleural,O
104271,26,effusion,O
104271,26,that,O
104271,26,was,O
104271,26,determined,O
104271,26,to,O
104271,26,be,O
104271,26,solid,O
104271,26,on,O
104271,26,thorocentesis,O
104271,26,(,O
104271,26,Path,O
104271,26,result,O
104271,26,is,O
104271,26,pending,O
104271,26,),O
104271,26,.,O
104271,27,These,O
104271,27,findings,O
104271,27,",",O
104271,27,in,O
104271,27,combination,O
104271,27,with,O
104271,27,his,O
104271,27,pulmonary,B-Reason
104271,27,hypertension,I-Reason
104271,27,and,O
104271,27,deconditioning,O
104271,27,were,O
104271,27,thought,O
104271,27,to,O
104271,27,account,O
104271,27,for,O
104271,27,the,O
104271,27,patient,O
104271,27,'s,O
104271,27,continued,O
104271,27,hypoxia,O
104271,27,.,O
104271,27,Diuresis,B-Drug
104271,27,was,O
104271,27,initiated,O
104271,27,the,O
104271,27,following,O
104271,27,day,O
104271,27,",",O
104271,27,and,O
104271,27,satrurations,O
104271,27,improved,O
104271,27,",",O
104271,27,but,O
104271,27,he,O
104271,27,continued,O
104271,27,to,O
104271,27,have,O
104271,27,an,O
104271,27,oxygen,O
104271,27,requirement,O
104271,27,.,O
104271,27,He,O
104271,27,had,O
104271,27,also,O
104271,27,been,O
104271,27,noted,O
104271,27,to,O
104271,27,have,O
104271,27,worsened,O
104271,27,dyspnea,O
104271,27,while,O
104271,27,ambulating,O
104271,27,",",O
104271,27,and,O
104271,27,a,O
104271,27,stress,O
104271,27,test,O
104271,27,was,O
104271,27,performed,O
104271,27,to,O
104271,27,rule-out,O
104271,27,an,O
104271,27,anginal,O
104271,27,component,O
104271,27,.,O
104271,27,Stress,O
104271,27,test,O
104271,27,was,O
104271,27,normal,O
104271,27,",",O
104271,27,showing,O
104271,27,no,O
104271,27,ECG,O
104271,27,changes,O
104271,27,or,O
104271,27,anginal,O
104271,27,component,O
104271,27,and,O
104271,27,normal,O
104271,27,myocardial,O
104271,27,perfusion,O
104271,27,with,O
104271,27,Ejection,O
104271,27,Fraction,O
104271,27,of,O
104271,27,71,O
104271,27,%,O
104271,27,.,O
104271,28,By,O
104271,28,discharge,O
104271,28,",",O
104271,28,oxygen,O
104271,28,saturations,O
104271,28,were,O
104271,28,98,O
104271,28,%,O
104271,28,on,O
104271,28,3L,O
104271,28,",",O
104271,28,and,O
104271,28,he,O
104271,28,was,O
104271,28,discharged,O
104271,28,home,O
104271,28,on,O
104271,28,2L,O
104271,28,oxygen,B-Drug
104271,28,via,O
104271,28,nasal,O
104271,28,cannula,O
104271,28,.,O
104271,28,.,O
104271,28,#,O
104271,28,.,O
104271,28,Acute,O
104271,28,Renal,O
104271,28,Failure,O
104271,28,:,O
104271,28,On,O
104271,28,admission,O
104271,28,",",O
104271,28,the,O
104271,28,patient,O
104271,28,had,O
104271,28,a,O
104271,28,creatinine,O
104271,28,level,O
104271,28,of,O
104271,28,3.4,O
104271,28,.,O
104271,28,This,O
104271,28,appeared,O
104271,28,to,O
104271,28,be,O
104271,28,related,O
104271,28,to,O
104271,28,a,O
104271,28,prerenal,O
104271,28,state,O
104271,28,",",O
104271,28,as,O
104271,28,supported,O
104271,28,by,O
104271,28,his,O
104271,28,history,O
104271,28,of,O
104271,28,very,O
104271,28,poor,O
104271,28,PO,O
104271,28,intake,O
104271,28,x,O
104271,28,10,O
104271,28,days,O
104271,28,and,O
104271,28,FENa,O
104271,28,<,O
104271,28,1,O
104271,28,%,O
104271,28,.,O
104271,28,The,O
104271,28,possibility,O
104271,28,of,O
104271,28,ATN,B-ADE
104271,28,from,O
104271,28,NSAIDs,B-Drug
104271,28,was,O
104271,28,also,O
104271,28,considered,O
104271,28,given,O
104271,28,his,O
104271,28,recent,O
104271,28,history,O
104271,28,of,O
104271,28,taking,O
104271,28,Motrin,B-Drug
104271,28,for,O
104271,28,pain,B-Reason
104271,28,",",O
104271,28,and,O
104271,28,renal,O
104271,28,followed,O
104271,28,the,O
104271,28,patient,O
104271,28,until,O
104271,28,Cr,O
104271,28,had,O
104271,28,improved,O
104271,28,.,O
104271,29,Renal,O
104271,29,ultrasound,O
104271,29,showed,O
104271,29,no,O
104271,29,hydronephrosis,O
104271,29,.,O
104271,29,Creatinine,O
104271,29,slowly,O
104271,29,improved,O
104271,29,with,O
104271,29,IVF,B-Drug
104271,29,and,O
104271,29,time,O
104271,29,",",O
104271,29,and,O
104271,29,had,O
104271,29,decreased,O
104271,29,to,O
104271,29,1.2,O
104271,29,by,O
104271,29,[,O
104271,29,*,O
104271,29,*,O
104271,29,1-16,O
104271,29,*,O
104271,29,*,O
104271,29,],O
104271,29,(,O
104271,29,most,O
104271,29,recent,O
104271,29,baseline,O
104271,29,measurement,O
104271,29,was,O
104271,29,1.1,O
104271,29,in,O
104271,29,[,O
104271,29,*,O
104271,29,*,O
104271,29,2140,O
104271,29,*,O
104271,29,*,O
104271,29,],O
104271,29,),O
104271,29,.,O
104271,29,When,O
104271,29,the,O
104271,29,patient,O
104271,29,'s,O
104271,29,home,O
104271,29,diuretics,B-Drug
104271,29,were,O
104271,29,subsequently,O
104271,29,restarted,O
104271,29,for,O
104271,29,hyponatremia,B-Reason
104271,29,and,O
104271,29,fluid,B-Reason
104271,29,overload,I-Reason
104271,29,",",O
104271,29,Cr,O
104271,29,rose,O
104271,29,again,O
104271,29,to,O
104271,29,1.6,O
104271,29,.,O
104271,29,By,O
104271,29,discharge,O
104271,29,",",O
104271,29,the,O
104271,29,patient,O
104271,29,'s,O
104271,29,creatinine,O
104271,29,was,O
104271,29,1.4.,O
104271,29,.,O
104271,29,#,O
104271,29,.,O
104271,30,Staph,B-Reason
104271,30,Bacteremia,I-Reason
104271,30,:,O
104271,30,Blood,O
104271,30,cultures,O
104271,30,on,O
104271,30,admission,O
104271,30,grew,O
104271,30,MSSA,O
104271,30,(,O
104271,30,4/4,O
104271,30,bottles,O
104271,30,from,O
104271,30,[,O
104271,30,*,O
104271,30,*,O
104271,30,1-7,O
104271,30,*,O
104271,30,*,O
104271,30,],O
104271,30,),O
104271,30,.,O
104271,30,Renally-dosed,O
104271,30,vancomycin,B-Drug
104271,30,was,O
104271,30,started,O
104271,30,on,O
104271,30,[,O
104271,30,*,O
104271,30,*,O
104271,30,1-8,O
104271,30,*,O
104271,30,*,O
104271,30,],O
104271,30,",",O
104271,30,then,O
104271,30,switched,O
104271,30,to,O
104271,30,oxacillin,B-Drug
104271,30,on,O
104271,30,[,O
104271,30,*,O
104271,30,*,O
104271,30,1-10,O
104271,30,*,O
104271,30,*,O
104271,30,],O
104271,30,when,O
104271,30,sensitivities,O
104271,30,returned,O
104271,30,.,O
104271,30,2/2,O
104271,30,blood,O
104271,30,cultures,O
104271,30,from,O
104271,30,[,O
104271,30,*,O
104271,30,*,O
104271,30,1-10,O
104271,30,*,O
104271,30,*,O
104271,30,],O
104271,30,also,O
104271,30,grew,O
104271,30,staph,O
104271,30,aureus,O
104271,30,.,O
104271,30,Surveillance,O
104271,30,cultures,O
104271,30,since,O
104271,30,then,O
104271,30,have,O
104271,30,been,O
104271,30,negative,O
104271,30,.,O
104271,30,TEE,O
104271,30,done,O
104271,30,[,O
104271,30,*,O
104271,30,*,O
104271,30,1-15,O
104271,30,*,O
104271,30,*,O
104271,30,],O
104271,30,not,O
104271,30,show,O
104271,30,any,O
104271,30,valvular,O
104271,30,abnormalities,O
104271,30,.,O
104271,31,A,O
104271,31,PICC,O
104271,31,line,O
104271,31,was,O
104271,31,placed,O
104271,31,on,O
104271,31,[,O
104271,31,*,O
104271,31,*,O
104271,31,1-12,O
104271,31,*,O
104271,31,*,O
104271,31,],O
104271,31,and,O
104271,31,the,O
104271,31,patient,O
104271,31,completed,O
104271,31,a,O
104271,31,14-day,O
104271,31,course,O
104271,31,of,O
104271,31,IV,O
104271,31,antibiotics,B-Drug
104271,31,on,O
104271,31,[,O
104271,31,*,O
104271,31,*,O
104271,31,2143-1-22,O
104271,31,*,O
104271,31,*,O
104271,31,],O
104271,31,and,O
104271,31,the,O
104271,31,PICC,O
104271,31,was,O
104271,31,removed,O
104271,31,prior,O
104271,31,to,O
104271,31,discharge,O
104271,31,.,O
104271,31,.,O
104271,31,#,O
104271,31,.,O
104271,31,Hyponatremia,B-Reason
104271,31,:,O
104271,31,While,O
104271,31,in,O
104271,31,the,O
104271,31,ICU,O
104271,31,",",O
104271,31,the,O
104271,31,patient,O
104271,31,had,O
104271,31,one,O
104271,31,set,O
104271,31,of,O
104271,31,serum,O
104271,31,chemistries,O
104271,31,with,O
104271,31,serum,O
104271,31,sodium,O
104271,31,of,O
104271,31,122,O
104271,31,.,O
104271,31,Remainder,O
104271,31,of,O
104271,31,values,O
104271,31,were,O
104271,31,in,O
104271,31,130s,O
104271,31,until,O
104271,31,fluids,O
104271,31,were,O
104271,31,started,O
104271,31,on,O
104271,31,[,O
104271,31,*,O
104271,31,*,O
104271,31,1-14,O
104271,31,*,O
104271,31,*,O
104271,31,],O
104271,31,in,O
104271,31,preparation,O
104271,31,for,O
104271,31,CTA,O
104271,31,with,O
104271,31,dye,O
104271,31,load,O
104271,31,.,O
104271,32,Next,O
104271,32,measured,O
104271,32,Na,O
104271,32,was,O
104271,32,127,O
104271,32,on,O
104271,32,[,O
104271,32,*,O
104271,32,*,O
104271,32,1-16,O
104271,32,*,O
104271,32,*,O
104271,32,],O
104271,32,.,O
104271,32,He,O
104271,32,was,O
104271,32,fluid,O
104271,32,restricted,O
104271,32,to,O
104271,32,1500cc/day,O
104271,32,and,O
104271,32,encouraged,O
104271,32,to,O
104271,32,improve,O
104271,32,his,O
104271,32,food,O
104271,32,intake,O
104271,32,",",O
104271,32,which,O
104271,32,had,O
104271,32,been,O
104271,32,poor,O
104271,32,throughout,O
104271,32,his,O
104271,32,admission,O
104271,32,.,O
104271,32,Given,O
104271,32,that,O
104271,32,he,O
104271,32,also,O
104271,32,had,O
104271,32,evidence,O
104271,32,of,O
104271,32,total,B-Reason
104271,32,body,I-Reason
104271,32,fluid,I-Reason
104271,32,overload,I-Reason
104271,32,(,O
104271,32,peripheral,O
104271,32,and,O
104271,32,abdominal,O
104271,32,edema,O
104271,32,),O
104271,32,",",O
104271,32,he,O
104271,32,was,O
104271,32,restarted,O
104271,32,on,O
104271,32,his,O
104271,32,home,O
104271,32,diuretic,B-Drug
104271,32,regimen,O
104271,32,of,O
104271,32,Lasix,B-Drug
104271,32,20mg,O
104271,32,and,O
104271,32,spironolactone,B-Drug
104271,32,25mg,O
104271,32,.,O
104271,32,By,O
104271,32,[,O
104271,32,*,O
104271,32,*,O
104271,32,1-22,O
104271,32,*,O
104271,32,*,O
104271,32,],O
104271,32,",",O
104271,32,Na,O
104271,32,had,O
104271,32,risen,O
104271,32,to,O
104271,32,131.,O
104271,32,.,O
104271,33,#,O
104271,33,.,O
104271,33,UTI,B-Reason
104271,33,:,O
104271,33,Urine,O
104271,33,labs,O
104271,33,from,O
104271,33,[,O
104271,33,*,O
104271,33,*,O
104271,33,1-9,O
104271,33,*,O
104271,33,*,O
104271,33,],O
104271,33,showed,O
104271,33,UTI,O
104271,33,",",O
104271,33,for,O
104271,33,which,O
104271,33,the,O
104271,33,patient,O
104271,33,was,O
104271,33,treated,O
104271,33,with,O
104271,33,a,O
104271,33,7,O
104271,33,day,O
104271,33,course,O
104271,33,of,O
104271,33,Levofloxacin,B-Drug
104271,33,that,O
104271,33,finished,O
104271,33,on,O
104271,33,[,O
104271,33,*,O
104271,33,*,O
104271,33,1-16,O
104271,33,*,O
104271,33,*,O
104271,33,],O
104271,33,.,O
104271,33,Urine,O
104271,33,Cx,O
104271,33,was,O
104271,33,negative,O
104271,33,",",O
104271,33,but,O
104271,33,was,O
104271,33,sent,O
104271,33,after,O
104271,33,the,O
104271,33,patient,O
104271,33,had,O
104271,33,started,O
104271,33,Levofloxacin,B-Drug
104271,33,and,O
104271,33,Vancomycin,B-Drug
104271,33,.,O
104271,33,Fever,O
104271,33,curve,O
104271,33,remained,O
104271,33,flat,O
104271,33,.,O
104271,33,.,O
104271,33,#,O
104271,33,.,O
104271,33,Anxiety,B-Reason
104271,33,:,O
104271,33,The,O
104271,33,patient,O
104271,33,consistently,O
104271,33,reported,O
104271,33,having,O
104271,33,a,O
104271,33,``,O
104271,33,nervous,O
104271,33,stomach,O
104271,33,'',O
104271,33,that,O
104271,33,felt,O
104271,33,like,O
104271,33,it,O
104271,33,had,O
104271,33,``,O
104271,33,knots,O
104271,33,in,O
104271,33,it,O
104271,33,.,O
104271,33,'',O
104271,34,He,O
104271,34,has,O
104271,34,had,O
104271,34,these,O
104271,34,sensations,O
104271,34,for,O
104271,34,many,O
104271,34,years,O
104271,34,",",O
104271,34,and,O
104271,34,reported,O
104271,34,that,O
104271,34,it,O
104271,34,made,O
104271,34,eating,O
104271,34,difficult,O
104271,34,because,O
104271,34,it,O
104271,34,caused,O
104271,34,him,O
104271,34,to,O
104271,34,feel,O
104271,34,nauseus,O
104271,34,.,O
104271,34,This,O
104271,34,was,O
104271,34,thought,O
104271,34,to,O
104271,34,be,O
104271,34,a,O
104271,34,manifestation,O
104271,34,of,O
104271,34,anxiety,B-Reason
104271,34,",",O
104271,34,and,O
104271,34,the,O
104271,34,patient,O
104271,34,was,O
104271,34,tried,O
104271,34,on,O
104271,34,0.5mg,O
104271,34,of,O
104271,34,Ativan,B-Drug
104271,34,.,O
104271,34,This,O
104271,34,was,O
104271,34,subsequently,O
104271,34,discontinued,O
104271,34,when,O
104271,34,he,O
104271,34,was,O
104271,34,found,O
104271,34,to,O
104271,34,be,O
104271,34,excessively,B-ADE
104271,34,somnolent,I-ADE
104271,34,.,O
104271,34,The,O
104271,34,patient,O
104271,34,agreed,O
104271,34,to,O
104271,34,start,O
104271,34,Remeron,B-Drug
104271,34,for,O
104271,34,help,O
104271,34,with,O
104271,34,anxiety,B-Reason
104271,34,and,O
104271,34,appetite,B-Reason
104271,34,stimulation,I-Reason
104271,34,.,O
104271,34,He,O
104271,34,tolerated,O
104271,34,it,O
104271,34,well,O
104271,34,and,O
104271,34,was,O
104271,34,discharged,O
104271,34,on,O
104271,34,15mg,O
104271,34,Remeron,B-Drug
104271,34,QHS,O
104271,34,.,O
104271,35,.,O
104271,35,#,O
104271,35,.,O
104271,35,DM,B-Reason
104271,35,:,O
104271,35,The,O
104271,35,patient,O
104271,35,recived,O
104271,35,QID,O
104271,35,finger,O
104271,35,sticks,O
104271,35,and,O
104271,35,was,O
104271,35,treated,O
104271,35,with,O
104271,35,bedtime,O
104271,35,glargine,B-Drug
104271,35,and,O
104271,35,ISS,B-Drug
104271,35,.,O
104271,35,Blood,O
104271,35,glucose,O
104271,35,measurments,O
104271,35,fluxuated,O
104271,35,with,O
104271,35,his,O
104271,35,PO,O
104271,35,intake,O
104271,35,and,O
104271,35,adjustments,O
104271,35,were,O
104271,35,made,O
104271,35,as,O
104271,35,appropriate,O
104271,35,.,O
104271,35,.,O
104271,35,#,O
104271,35,.,O
104271,35,Hypertension,B-Reason
104271,35,/,O
104271,35,CAD,B-Reason
104271,35,:,O
104271,35,The,O
104271,35,patient,O
104271,35,was,O
104271,35,treated,O
104271,35,with,O
104271,35,ASA,B-Drug
104271,35,325mg,O
104271,35,and,O
104271,35,Metoprolol,B-Drug
104271,35,12.5mg,O
104271,35,TID,O
104271,35,.,O
104271,35,As,O
104271,35,the,O
104271,35,patient,O
104271,35,had,O
104271,35,no,O
104271,35,apparent,O
104271,35,indication,O
104271,35,for,O
104271,35,digoxin,B-Drug
104271,35,",",O
104271,35,this,O
104271,35,was,O
104271,35,held,O
104271,35,during,O
104271,35,his,O
104271,35,hospitalization,O
104271,35,.,O
104271,35,He,O
104271,35,was,O
104271,35,discharged,O
104271,35,on,O
104271,35,atenolol,B-Drug
104271,35,12.5mg,O
104271,35,daily,O
104271,35,and,O
104271,35,ASA,B-Drug
104271,35,325mg,O
104271,35,daily,O
104271,35,.,O
104271,36,Stress,O
104271,36,test,O
104271,36,revealed,O
104271,36,no,O
104271,36,hypoperfusion,O
104271,36,at,O
104271,36,rest,O
104271,36,or,O
104271,36,with,O
104271,36,persantine,B-Drug
104271,36,stimulation,O
104271,36,.,O
104271,36,.,O
104271,36,#,O
104271,36,.,O
104271,36,Nutrition,O
104271,36,:,O
104271,36,Albumin,O
104271,36,was,O
104271,36,2.6,O
104271,36,on,O
104271,36,admission,O
104271,36,",",O
104271,36,2.4,O
104271,36,on,O
104271,36,[,O
104271,36,*,O
104271,36,*,O
104271,36,1-16,O
104271,36,*,O
104271,36,*,O
104271,36,],O
104271,36,.,O
104271,36,The,O
104271,36,patient,O
104271,36,reported,O
104271,36,a,O
104271,36,10,O
104271,36,day,O
104271,36,history,O
104271,36,of,O
104271,36,anorexia,O
104271,36,on,O
104271,36,admission,O
104271,36,and,O
104271,36,continued,O
104271,36,to,O
104271,36,have,O
104271,36,poor,O
104271,36,PO,O
104271,36,intake,O
104271,36,throughout,O
104271,36,most,O
104271,36,of,O
104271,36,his,O
104271,36,hospitalization,O
104271,36,.,O
104271,36,He,O
104271,36,cited,O
104271,36,lack,O
104271,36,of,O
104271,36,appetite,O
104271,36,and,O
104271,36,nausea,O
104271,36,caused,O
104271,36,by,O
104271,36,his,O
104271,36,``,O
104271,36,nervous,O
104271,36,stomach,O
104271,36,'',O
104271,36,as,O
104271,36,reasons,O
104271,36,for,O
104271,36,his,O
104271,36,poor,O
104271,36,intake,O
104271,36,.,O
104271,37,The,O
104271,37,patient,O
104271,37,was,O
104271,37,maintained,O
104271,37,on,O
104271,37,a,O
104271,37,renal,O
104271,37,diet,O
104271,37,with,O
104271,37,liquid,O
104271,37,supplements,O
104271,37,(,O
104271,37,Boost,O
104271,37,),O
104271,37,TID,O
104271,37,.,O
104271,37,He,O
104271,37,had,O
104271,37,poor,O
104271,37,compliance,O
104271,37,until,O
104271,37,2,O
104271,37,days,O
104271,37,prior,O
104271,37,to,O
104271,37,discharge,O
104271,37,",",O
104271,37,when,O
104271,37,he,O
104271,37,reported,O
104271,37,an,O
104271,37,increase,O
104271,37,in,O
104271,37,appetite,O
104271,37,and,O
104271,37,improved,O
104271,37,PO,O
104271,37,intake,O
104271,37,was,O
104271,37,recorded,O
104271,37,.,O
104271,37,.,O
104271,37,#,O
104271,37,.,O
104271,37,Hemochromatosis/cirrhosis,O
104271,37,:,O
104271,37,Remained,O
104271,37,stable,O
104271,37,during,O
104271,37,this,O
104271,37,hospitalization,O
104271,37,.,O
104271,37,.,O
104271,37,#,O
104271,37,.,O
104271,37,Hypothyroidism,B-Reason
104271,37,:,O
104271,37,Remained,O
104271,37,stable,O
104271,37,.,O
104271,37,He,O
104271,37,was,O
104271,37,treated,O
104271,37,with,O
104271,37,his,O
104271,37,home,O
104271,37,dose,O
104271,37,of,O
104271,37,Levothyroxine,B-Drug
104271,37,100,O
104271,37,mcg,O
104271,37,daily,O
104271,37,during,O
104271,37,this,O
104271,37,admission,O
104271,37,.,O
104271,38,.,O
104271,38,#,O
104271,38,Physical,O
104271,38,Therapy,O
104271,38,:,O
104271,38,The,O
104271,38,patient,O
104271,38,was,O
104271,38,evaluated,O
104271,38,and,O
104271,38,followed,O
104271,38,by,O
104271,38,PT,O
104271,38,",",O
104271,38,who,O
104271,38,felt,O
104271,38,he,O
104271,38,was,O
104271,38,safe,O
104271,38,to,O
104271,38,return,O
104271,38,to,O
104271,38,his,O
104271,38,daugter,O
104271,38,'s,O
104271,38,home,O
104271,38,.,O
104271,38,.,O
104271,38,#,O
104271,38,Prophylaxis,B-Reason
104271,38,:,O
104271,38,The,O
104271,38,patient,O
104271,38,was,O
104271,38,treated,O
104271,38,with,O
104271,38,incentive,O
104271,38,spirometry,O
104271,38,",",O
104271,38,H2,B-Drug
104271,38,blocker,I-Drug
104271,38,",",O
104271,38,and,O
104271,38,SC,O
104271,38,heparin,B-Drug
104271,38,(,O
104271,38,which,O
104271,38,was,O
104271,38,discontinued,O
104271,38,when,O
104271,38,he,O
104271,38,began,O
104271,38,ambulating,O
104271,38,),O
104271,38,.,O
104271,38,#,O
104271,38,.,O
104271,38,Abnormal,O
104271,38,tests,O
104271,38,requiring,O
104271,38,outpatient,O
104271,38,follow-up,O
104271,38,:,O
104271,38,Seen,O
104271,38,on,O
104271,38,CTA,O
104271,38,[,O
104271,38,*,O
104271,38,*,O
104271,38,2143-1-16,O
104271,38,*,O
104271,38,*,O
104271,38,],O
104271,38,:,O
104271,38,1,O
104271,38,.,O
104271,39,3mm,O
104271,39,pulmonary,O
104271,39,nodule,O
104271,39,in,O
104271,39,the,O
104271,39,right,O
104271,39,middle,O
104271,39,lobe,O
104271,39,.,O
104271,39,2.,O
104271,39,hypodense,O
104271,39,oval,O
104271,39,lesion,O
104271,39,approx,O
104271,39,8mm,O
104271,39,at,O
104271,39,the,O
104271,39,liver,O
104271,39,dome,O
104271,39,.,O
104271,39,Recommend,O
104271,39,follow-up,O
104271,39,CT,O
104271,39,in,O
104271,39,1,O
104271,39,year,O
104271,39,.,O
104271,39,Medications,O
104271,39,on,O
104271,39,Admission,O
104271,39,:,O
104271,39,Meds,O
104271,39,on,O
104271,39,admission,O
104271,39,:,O
104271,39,*,O
104271,39,Spironolactone,B-Drug
104271,39,25mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Lasix,B-Drug
104271,39,20mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Digoxin,B-Drug
104271,39,0.125mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Synthroid,B-Drug
104271,39,0.1mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Folic,B-Drug
104271,39,Acid,I-Drug
104271,39,1mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Diltiazem,B-Drug
104271,39,30mg,O
104271,39,daily,O
104271,39,*,O
104271,39,insulin,B-Drug
104271,39,Discharge,O
104271,39,Medications,O
104271,39,:,O
104271,39,*,O
104271,39,Spironolactone,B-Drug
104271,39,25mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Furosemide,B-Drug
104271,39,20mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Synthroid,B-Drug
104271,39,0.1mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Folic,B-Drug
104271,39,Acid,I-Drug
104271,39,1mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Diltiazem,B-Drug
104271,39,30mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Mirtazapine,B-Drug
104271,39,15mg,O
104271,39,at,O
104271,39,bedtime,O
104271,39,*,O
104271,39,Aspirin,B-Drug
104271,39,81mg,O
104271,39,daily,O
104271,39,*,O
104271,39,Combivent,B-Drug
104271,39,103-18,O
104271,39,mcg/Actuation,O
104271,39,Aerosol,O
104271,40,1,O
104271,40,puff,O
104271,40,QID,O
104271,40,*,O
104271,40,Oxygen,B-Drug
104271,40,2-3L,O
104271,40,via,O
104271,40,nasal,O
104271,40,cannula,O
104271,40,to,O
104271,40,keep,O
104271,40,O2,B-Reason
104271,40,sat,I-Reason
104271,40,>,I-Reason
104271,40,94,I-Reason
104271,40,%,O
104271,40,*,O
104271,40,insulin,B-Drug
104271,40,Discharge,O
104271,40,Disposition,O
104271,40,:,O
104271,40,Home,O
104271,40,With,O
104271,40,Service,O
104271,40,Facility,O
104271,40,:,O
104271,40,[,O
104271,40,*,O
104271,40,*,O
104271,40,Hospital,O
104271,40,2255,O
104271,40,*,O
104271,40,*,O
104271,40,],O
104271,40,[,O
104271,40,*,O
104271,40,*,O
104271,40,Name,O
104271,40,(,O
104271,40,NI,O
104271,40,),O
104271,40,2256,O
104271,40,*,O
104271,40,*,O
104271,40,],O
104271,40,Discharge,O
104271,40,Diagnosis,O
104271,40,:,O
104271,40,1,O
104271,40,.,O
104271,40,Staph,O
104271,40,aureus,O
104271,40,bacteremia,O
104271,40,2,O
104271,40,.,O
104271,40,Pulmonary,O
104271,40,hypertension,O
104271,40,3,O
104271,40,.,O
104271,40,Acute,O
104271,40,renal,O
104271,40,failure,O
104271,40,4,O
104271,40,.,O
104271,40,Lactic,O
104271,40,acidosis,O
104271,40,5,O
104271,40,.,O
104271,40,Dibetes,O
104271,40,mellitus,O
104271,40,6.,O
104271,40,hemochromatosis/cirrhosis,O
104271,40,Discharge,O
104271,40,Condition,O
104271,40,:,O
104271,40,Stable,O
104271,40,.,O
104271,41,Requiring,O
104271,41,supplemental,O
104271,41,oxygen,B-Drug
104271,41,at,O
104271,41,2L,O
104271,41,via,O
104271,41,nasal,O
104271,41,cannula,O
104271,41,.,O
104271,41,Discharge,O
104271,41,Instructions,O
104271,41,:,O
104271,41,1,O
104271,41,.,O
104271,41,Call,O
104271,41,your,O
104271,41,doctor,O
104271,41,or,O
104271,41,go,O
104271,41,to,O
104271,41,the,O
104271,41,ER,O
104271,41,for,O
104271,41,:,O
104271,41,-,O
104271,41,fever,O
104271,41,>,O
104271,41,101,O
104271,41,-,O
104271,41,chest,O
104271,41,pain,O
104271,41,",",O
104271,41,shortness,O
104271,41,of,O
104271,41,breath,O
104271,41,",",O
104271,41,weakness,O
104271,41,-,O
104271,41,other,O
104271,41,concerns,O
104271,41,2,O
104271,41,.,O
104271,41,Please,O
104271,41,use,O
104271,41,wear,O
104271,41,your,O
104271,41,oxygen,O
104271,41,at,O
104271,41,all,O
104271,41,times,O
104271,41,.,O
104271,41,Avoid,O
104271,41,smoking,O
104271,41,or,O
104271,41,open,O
104271,41,flames,O
104271,41,as,O
104271,41,oxygen,B-Drug
104271,41,is,O
104271,41,flammable,O
104271,41,.,O
104271,41,3,O
104271,41,.,O
104271,41,Please,O
104271,41,take,O
104271,41,all,O
104271,41,of,O
104271,41,your,O
104271,41,medications,O
104271,41,as,O
104271,41,prescribed,O
104271,41,5,O
104271,41,.,O
104271,41,Take,O
104271,41,the,O
104271,41,Ensure,O
104271,41,supplement,O
104271,41,drinks,O
104271,41,three,O
104271,41,times,O
104271,41,a,O
104271,41,day,O
104271,41,;,O
104271,41,these,O
104271,41,can,O
104271,41,be,O
104271,41,purchased,O
104271,41,at,O
104271,41,most,O
104271,41,pharmacies,O
104271,41,.,O
104271,42,Followup,O
104271,42,Instructions,O
104271,42,:,O
104271,42,1,O
104271,42,.,O
104271,42,DR.,O
104271,42,[,O
104271,42,*,O
104271,42,*,O
104271,42,Last,O
104271,42,Name,O
104271,42,(,O
104271,42,STitle,O
104271,42,),O
104271,42,*,O
104271,42,*,O
104271,42,],O
104271,42,[,O
104271,42,*,O
104271,42,*,O
104271,42,2143-1-24,O
104271,42,*,O
104271,42,*,O
104271,42,],O
104271,42,at,O
104271,42,9:15,O
104271,42,AM,O
104271,42,[,O
104271,42,*,O
104271,42,*,O
104271,42,Telephone/Fax,O
104271,42,(,O
104271,42,1,O
104271,42,),O
104271,42,1983,O
104271,42,*,O
104271,42,*,O
104271,42,],O
104271,42,(,O
104271,42,Please,O
104271,42,call,O
104271,42,before,O
104271,42,appointment,O
104271,42,to,O
104271,42,update,O
104271,42,your,O
104271,42,registration,O
104271,42,information,O
104271,42,),O
104271,42,2,O
104271,42,.,O
104271,42,SLEEP,O
104271,42,STUDY-Office,O
104271,42,will,O
104271,42,call,O
104271,42,you,O
104271,42,to,O
104271,42,schedule,O
104271,42,appointment,O
104271,42,.,O
104271,42,You,O
104271,42,can,O
104271,42,contact,O
104271,42,them,O
104271,42,at,O
104271,42,[,O
104271,42,*,O
104271,42,*,O
104271,42,Telephone/Fax,O
104271,42,(,O
104271,42,1,O
104271,42,),O
104271,42,16716,O
104271,42,*,O
104271,42,*,O
104271,42,],O
104271,42,3,O
104271,42,.,O
104271,43,PULMONARY,O
104271,43,FUNCTION,O
104271,43,TESTS,O
104271,43,:,O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,2143-2-14,O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,11:30AM,O
104271,43,(,O
104271,43,Please,O
104271,43,go,O
104271,43,to,O
104271,43,the,O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,Hospital,O
104271,43,Ward,O
104271,43,Name,O
104271,43,23,O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,building,O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,Location,O
104271,43,(,O
104271,43,un,O
104271,43,),O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,&,O
104271,43,check-in,O
104271,43,at,O
104271,43,Rehab,O
104271,43,Services,O
104271,43,),O
104271,43,4,O
104271,43,.,O
104271,43,DR.,O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,First,O
104271,43,Name4,O
104271,43,(,O
104271,43,NamePattern1,O
104271,43,),O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,Last,O
104271,43,Name,O
104271,43,(,O
104271,43,NamePattern1,O
104271,43,),O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,(,O
104271,43,PULMONARY,O
104271,43,),O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,2143-2-14,O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,1:10PM,O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,Telephone/Fax,O
104271,43,(,O
104271,43,1,O
104271,43,),O
104271,43,612,O
104271,43,*,O
104271,43,*,O
104271,43,],O
104271,43,[,O
104271,43,*,O
104271,43,*,O
104271,43,Name6,O
104271,43,(,O
104271,43,MD,O
104271,43,),O
104271,43,*,O
104271,43,*,O
104271,44,],O
104271,44,[,O
104271,44,*,O
104271,44,*,O
104271,44,Name8,O
104271,44,(,O
104271,44,MD,O
104271,44,),O
104271,44,*,O
104271,44,*,O
104271,44,],O
104271,44,MD,O
104271,44,[,O
104271,44,*,O
104271,44,*,O
104271,44,MD,O
104271,44,Number,O
104271,44,(,O
104271,44,2,O
104271,44,),O
104271,44,2158,O
104271,44,*,O
104271,44,*,O
104271,44,],O
